Company intelligence / Profile preview

BioSecurity Technology

Ownership: Private
Development stage: Commercial

Overview

BioSecurity Technology develops and markets advanced disinfection solutions focused on the elimination of biofilms to prevent bacterial and viral attachment. Their proprietary platform is used globally by major corporations for infection prevention. The company’s founder is a recognized expert in pathogenic substance control with extensive patent holdings.

Therapeutic areas: Infectious Diseases
Modalities: Device (disinfection systems)Engineered water and gas-based disinfection products
Industry: Non-Drug Biotech

Partnerships

NSA Supplier Partner program participant

Beyond the preview

Go deeper on BioSecurity Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSecurity Technology.

Explore the full profile